Full article: KEYNOTE-859: a Phase III Study of Pembrolizumab Plus Chemotherapy in Gastric/Gastroesophageal Junction Adenocarcinoma
CURRENT Diagnosis & Treatment Occupational & Environmental Medicine, 6th Edition (Current Occupational and Environmental Medicine),ESMO 2024: Clinical Prognostic Factors Within the High-Volume Subgroup of Metastatic Hormone Sensitive Prostate Cancer in ENZAMET (ANZUP 1304),Full article: KEYNOTE-859: a Phase III Study of Pembrolizumab Plus Chemotherapy in Gastric/Gastroesophageal Junction Adenocarcinoma,Program Day 2 - Sunday 27.10.24 - ISHL13 - International Symposium on Hodgkin Lymphoma